Gender Differences and Cardiometabolic Risk: The Importance of the Risk Factors.
Antonella MeloniChristian Cadeddu DessalviLucia CugusiMaria Pia DonataccioMartino DeiddaSusanna SciomerSabina GallinaCristina VassalleFederica MoscucciGiuseppe MercuroSilvia MaffeiPublished in: International journal of molecular sciences (2023)
Metabolic syndrome (Mets) is a clinical condition characterized by a cluster of major risk factors for cardiovascular disease (CVD) and type 2 diabetes: proatherogenic dyslipidemia, elevated blood pressure, dysglycemia, and abdominal obesity. Each risk factor has an independent effect, but, when aggregated, they become synergistic, doubling the risk of developing cardiovascular diseases and causing a 1.5-fold increase in all-cause mortality. We will highlight gender differences in the epidemiology, etiology, pathophysiology, and clinical expression of the aforementioned Mets components. Moreover, we will discuss gender differences in new biochemical markers of metabolic syndrome and cardiovascular risk.
Keyphrases
- metabolic syndrome
- risk factors
- cardiovascular disease
- type diabetes
- insulin resistance
- blood pressure
- cardiovascular risk factors
- uric acid
- poor prognosis
- heart rate
- adipose tissue
- glycemic control
- cardiovascular events
- weight gain
- hypertensive patients
- skeletal muscle
- blood glucose
- body mass index
- long non coding rna